Skip to main content
Erschienen in: World Journal of Urology 4/2010

01.08.2010 | Original Article

Maspin modulates adhesion of bladder carcinoma cells to vascular endothelium

verfasst von: Eva Juengel, Wolf-Dietrich C. Beecken, Santhosh Mundiyanapurath, Tobias Engl, Dietger Jonas, Roman A. Blaheta

Erschienen in: World Journal of Urology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Maspin belongs to the serpin family and has been shown to suppress tumor growth and metastasis in several tumor types. The role of maspin in bladder carcinoma has not been fully elucidated, and the object of this study was to investigate whether maspin contributes to bladder tumor adhesion to vascular endothelial cells (HUVEC).

Methods

Expression of maspin-coding mRNA was evaluated in a panel of bladder carcinoma cell lines. Maspin distribution in maspin mRNAhigh versus maspin mRNAlow cells was further analyzed by flow cytometry and confocal microscopy. Adhesion to HUVEC was measured in a coculture model and correlated with the surface-bound maspin.

Results

Maspinhigh (RT-4, RT-112) cell lines strongly attached to HUVEC, whereas maspinlow (UMUC-3, MGH-U1) cell lines poorly adhered to HUVEC. Distinct cytoplasmic maspin accumulation and moderate surface-bound maspin was found in RT-4 cells. Blocking maspin surface receptors prevented tumor cell attachment to HUVEC, indicating that surface-bound maspin is responsible for triggering cell adhesion. PMA-triggered elevation of surface-bound maspin was accompanied by an enhanced adhesion capacity of RT-4 cells, compared to controls. Finally, exposing the bladder carcinoma cells to the differentiation-inducing agent valproic acid led to a surface-bound (but not cytoplasmic) maspin decrease, paralleled by a significant reduction in tumor cell binding to HUVEC.

Conclusion

Surface-bound maspin directly controls bladder carcinoma cell adhesion to the vascular wall. Blocking this process may prevent transendothelial migration and tumor cell dissemination. Therefore, therapeutic down-regulation of surface-bound maspin might become an option to prevent tumor spread into distant organs.
Literatur
1.
Zurück zum Zitat Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526–529CrossRefPubMed Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526–529CrossRefPubMed
3.
Zurück zum Zitat Joensuu KM, Leidenius MH, Andersson LC, Heikkilä PS (2009) High expression of maspin is associated with early tumor relapse in breast cancer. Hum Pathol 40:1143–1151CrossRefPubMed Joensuu KM, Leidenius MH, Andersson LC, Heikkilä PS (2009) High expression of maspin is associated with early tumor relapse in breast cancer. Hum Pathol 40:1143–1151CrossRefPubMed
4.
Zurück zum Zitat Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS (2008) Maspin reduces prostate cancer metastasis to bone. Urol Oncol 26:652–658PubMed Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS (2008) Maspin reduces prostate cancer metastasis to bone. Urol Oncol 26:652–658PubMed
5.
Zurück zum Zitat Yoshizawa K, Nozaki S, Okamune A, Kitahara H, Ohara T, Kato K, Kawashiri S, Yamamoto E (2009) Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. J Oral Pathol Med 38:535–539CrossRefPubMed Yoshizawa K, Nozaki S, Okamune A, Kitahara H, Ohara T, Kato K, Kawashiri S, Yamamoto E (2009) Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. J Oral Pathol Med 38:535–539CrossRefPubMed
6.
Zurück zum Zitat Chua R, Setzer S, Govindarajan B, Sexton D, Cohen C, Arbiser JL (2009) Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. J Am Acad Dermatol 60:758–766CrossRefPubMed Chua R, Setzer S, Govindarajan B, Sexton D, Cohen C, Arbiser JL (2009) Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. J Am Acad Dermatol 60:758–766CrossRefPubMed
7.
Zurück zum Zitat Frey A, Soubani AO, Adam AK, Sheng S, Pass HI, Lonardo F (2009) Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival. Histopathology 54:590–597CrossRefPubMed Frey A, Soubani AO, Adam AK, Sheng S, Pass HI, Lonardo F (2009) Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival. Histopathology 54:590–597CrossRefPubMed
8.
Zurück zum Zitat Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2007) Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27:259–265PubMed Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y (2007) Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27:259–265PubMed
9.
Zurück zum Zitat Klasa-Mazurkiewicz D, Narkiewicz J, Milczek T, Lipińska B, Emerich J (2009) Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Gynecol Oncol 113:91–98CrossRefPubMed Klasa-Mazurkiewicz D, Narkiewicz J, Milczek T, Lipińska B, Emerich J (2009) Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Gynecol Oncol 113:91–98CrossRefPubMed
10.
Zurück zum Zitat Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y (2007) Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 38:1248–1255CrossRefPubMed Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y (2007) Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 38:1248–1255CrossRefPubMed
11.
Zurück zum Zitat Terashima M, Maesawa C, Oyama K, Ohtani S, Akiyama Y, Ogasawara S, Takagane A, Saito K, Masuda T, Kanzaki N, Matsuyama S, Hoshino Y, Kogure M, Gotoh M, Shirane M, Mori K (2005) Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92:1130–1136CrossRefPubMed Terashima M, Maesawa C, Oyama K, Ohtani S, Akiyama Y, Ogasawara S, Takagane A, Saito K, Masuda T, Kanzaki N, Matsuyama S, Hoshino Y, Kogure M, Gotoh M, Shirane M, Mori K (2005) Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92:1130–1136CrossRefPubMed
12.
Zurück zum Zitat Beecken WD, Engl T, Engels K, Blumenberg C, Oppermann E, Camphausen K, Shing Y, Reinecke G, Jonas D, Blaheta R (2006) Clinical relevance of maspin expression in bladder cancer. World J Urol 24:338–344CrossRefPubMed Beecken WD, Engl T, Engels K, Blumenberg C, Oppermann E, Camphausen K, Shing Y, Reinecke G, Jonas D, Blaheta R (2006) Clinical relevance of maspin expression in bladder cancer. World J Urol 24:338–344CrossRefPubMed
13.
Zurück zum Zitat Bal N, Kocer NE, Ertorer ME, Canpolat ET, Kayaselcuk F (2008) Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol Res Pract 204:743–750CrossRefPubMed Bal N, Kocer NE, Ertorer ME, Canpolat ET, Kayaselcuk F (2008) Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol Res Pract 204:743–750CrossRefPubMed
14.
Zurück zum Zitat Cella N, Contreras A, Latha K, Rosen JM, Zhang M (2006) Maspin is physically associated with [beta]1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J 20:1510–1512CrossRefPubMed Cella N, Contreras A, Latha K, Rosen JM, Zhang M (2006) Maspin is physically associated with [beta]1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J 20:1510–1512CrossRefPubMed
15.
Zurück zum Zitat Ngamkitidechakul C, Warejcka DJ, Burke JM, O’Brien WJ, Twining SS (2003) Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem 278:31796–31806CrossRefPubMed Ngamkitidechakul C, Warejcka DJ, Burke JM, O’Brien WJ, Twining SS (2003) Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem 278:31796–31806CrossRefPubMed
16.
Zurück zum Zitat Abraham S, Zhang W, Greenberg N, Zhang M (2003) Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol 169:1157–1161CrossRefPubMed Abraham S, Zhang W, Greenberg N, Zhang M (2003) Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol 169:1157–1161CrossRefPubMed
17.
Zurück zum Zitat Blacque OE, Worrall DM (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783–10788CrossRefPubMed Blacque OE, Worrall DM (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783–10788CrossRefPubMed
18.
Zurück zum Zitat Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H (2009) Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer. Cancer Res 69:8386–8394CrossRefPubMed Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H (2009) Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer. Cancer Res 69:8386–8394CrossRefPubMed
19.
Zurück zum Zitat McKenzie S, Sakamoto S, Kyprianou N (2008) Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 27:7171–7179CrossRefPubMed McKenzie S, Sakamoto S, Kyprianou N (2008) Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 27:7171–7179CrossRefPubMed
20.
Zurück zum Zitat Blandamura S, D’Alessandro E, Giacomelli L, Guzzardo V, Battanello W, Repele M, Ninfo V (2008) Expression of maspin in papillary Ta/T1 bladder neoplasms. Anticancer Res 28:471–478PubMed Blandamura S, D’Alessandro E, Giacomelli L, Guzzardo V, Battanello W, Repele M, Ninfo V (2008) Expression of maspin in papillary Ta/T1 bladder neoplasms. Anticancer Res 28:471–478PubMed
21.
Zurück zum Zitat Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H (2004) Expression of maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 45:737–743CrossRefPubMed Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H (2004) Expression of maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 45:737–743CrossRefPubMed
22.
Zurück zum Zitat Sugimoto S, Maass N, Takimoto Y, Sato K, Minei S, Zhang M, Hoshikawa Y, Jünemann KP, Jonat W, Nagasaki K (2004) Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett 203:209–215CrossRefPubMed Sugimoto S, Maass N, Takimoto Y, Sato K, Minei S, Zhang M, Hoshikawa Y, Jünemann KP, Jonat W, Nagasaki K (2004) Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett 203:209–215CrossRefPubMed
Metadaten
Titel
Maspin modulates adhesion of bladder carcinoma cells to vascular endothelium
verfasst von
Eva Juengel
Wolf-Dietrich C. Beecken
Santhosh Mundiyanapurath
Tobias Engl
Dietger Jonas
Roman A. Blaheta
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 4/2010
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0539-1

Weitere Artikel der Ausgabe 4/2010

World Journal of Urology 4/2010 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.